Sunday 27 September 2020
Home      All news      Contact us      RSS      India
business-standard - 18 days ago

Cadila Healthcare gets USFDA nod for diabetes drug

The drug major received tentative approval from the US drug regulator to market Empagliflozin and Linagliptin tablets in the strengths of 10 mg/5 mg and 25 mg/5 mg.


Latest News
Hashtags:   

Cadila

 | 

Healthcare

 | 

USFDA

 | 

diabetes

 | 

Sources